(Q41061384)

26 September 2017

1 reference

title

Treatment of Gaucher disease with an enzyme inhibitor (English)

1 reference

26 September 2017

1 reference

N S Radin

1

1 reference

26 September 2017

publication date

1 April 1996

1 reference

26 September 2017

published in

Glycoconjugate Journal

1 reference

26 September 2017

volume

13

1 reference

26 September 2017

issue

2

1 reference

26 September 2017

page(s)

153-157

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00731489

26 September 2017

exact match

0 references

cites work

Metabolism of D-[3H]threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol, an inhibitor of glucosylceramide synthesis, and the synergistic action of an inhibitor of microsomal monooxygenase

1 reference

12 December 2020

A ceramide analogue (PDMP) inhibits glycolipid synthesis in fish embryos

1 reference

12 December 2020

Brain glucocerebrosidase in Gaucher's disease

1 reference

12 December 2020

Inhibition of sphingolipid synthesis by cycloserine in vitro and in vivo

1 reference

12 December 2020

Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growth.

1 reference

12 December 2020

Effects of D-threo-PDMP, an inhibitor of glucosylceramide synthetase, on expression of cell surface glycolipid antigen and binding to adhesive proteins by B16 melanoma cells

1 reference

12 December 2020

Uptake by neuroblastoma cells of glucosylceramide, glucosylceramide glucosidase, its stimulator protein, and phosphatidylserine

1 reference

12 December 2020

Stimulation of liver growth and DNA synthesis by glucosylceramide

1 reference

12 December 2020

Normalization of liver glucosylceramide levels in the “Gaucher” mouse by phosphatidylserine injection

1 reference

12 December 2020

Preparation of the active isomer of 1-phenyl-2-decanoylamino-3-morpholino-1-propanol, inhibitor of murine glucocerebroside synthetase

1 reference

12 December 2020

Increased risk of cancer in patients with Gaucher disease

1 reference

12 December 2020

Rapid kidney changes resulting from glycosphingolipid depletion by treatment with a glucosyltransferase inhibitor

1 reference

12 December 2020

N-butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing

1 reference

12 December 2020

A role for glycosphingolipid accumulation in the renal hypertrophy of streptozotocin-induced diabetes mellitus

1 reference

12 December 2020

Human glucocerebrosidase catalyses transglucosylation between glucocerebroside and retinol

1 reference

12 December 2020

Effects of the glucosphingolipid synthesis inhibitor, PDMP, on lysosomes in cultured cells

1 reference

12 December 2020

Epithelial glucosphingolipid expression as a determinant of bacterial adherence and cytokine production

1 reference

12 December 2020

Antitumor activity via inhibition of glycosphingolipid biosynthesis.

1 reference

12 December 2020

Control of kidney size by sex hormones: possible involvement of glucosylceramide

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00731489

1 reference

Dimensions Publication ID

26 September 2017

1001541143

0 references

1 reference